Actively Recruiting
Role of the Gut Microbiome in Anti-tumor Therapy Induced Diarrhea
Led by Medical University of Graz · Updated on 2025-11-25
150
Participants Needed
1
Research Sites
605 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The role of the gut microbiome in the development of side effects of anti cancer treatment will be assessed in this longitudinal cohort study.
CONDITIONS
Official Title
Role of the Gut Microbiome in Anti-tumor Therapy Induced Diarrhea
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
- Starting a systemic anti-cancer therapy
- Able and willing to give informed consent
You will not qualify if you...
- Pre-existing diarrhea
- Antibiotic therapy within 4 weeks before inclusion
- Probiotic treatment within 4 weeks before inclusion
- Unable to give informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Internal Medicine, Medical University of Graz
Graz, Austria, 8010
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here